Endo to Buy Auxilium for $2.6 Billion to Gain Men’s Drugs
Endo International Plc (ENDP) agreed to buy Auxilium Pharmaceuticals Inc. (AUXL) for about $2.6 billion to gain testosterone products. Endo will pay $33.25 a share, and Auxilium holders will be able to choose cash, stock or a combination of the two, the companies said today in a statement. The price… – Continue reading